1. Home
  2. POLA vs ALZN Comparison

POLA vs ALZN Comparison

Compare POLA & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.45

Market Cap

4.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.33

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
ALZN
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
POLA
ALZN
Price
$1.45
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
31.2K
115.1K
Earning Date
04-15-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.77
EPS
N/A
N/A
Revenue
$24,801,141.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$1.31
$0.84
52 Week High
$5.70
$2.89

Technical Indicators

Market Signals
Indicator
POLA
ALZN
Relative Strength Index (RSI) 34.07 60.73
Support Level $1.35 $1.04
Resistance Level $1.76 $2.25
Average True Range (ATR) 0.09 0.10
MACD -0.01 0.01
Stochastic Oscillator 0.00 89.56

Price Performance

Historical Comparison
POLA
ALZN

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: